Khan, Suliman
Zhengzhou University,
China
2025 Rank: 84369
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3624 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84369 | 92514 |
| Total Cites | 959 | 1002 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 333 | 344 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 365 | 376 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 925 | 949 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.06 |
| Self-Citation Percentage |
4.29%
|
|
Khan, Suliman
Zhengzhou University,
China
2024 Rank: 89390
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 2963 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89390 | 86540 |
| Total Cites | 989 | 1055 |
| H-index | 13 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 296 | 317 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 335 | 358 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 978 | 1012 |
| Ratio of Total Citations to Distinct Citing Papers | 1.01 | 1.04 |
| Self-Citation Percentage |
6.26%
|
|
Khan, Suliman
Zhengzhou University,
China
2023 Rank: 82107
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3963 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82107 | 72217 |
| Total Cites | 1158 | 1292 |
| H-index | 12 | 15 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 347 | 391 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 390 | 437 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1136 | 1202 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.07 |
| Self-Citation Percentage |
10.37%
|
|
Khan, Suliman
Zhengzhou University,
China
2021 Rank: 95854
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Plant Biology & Botany
Rank in SubField 1: 2139 out of 165244 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95854 | 95529 |
| Total Cites | 1653 | 1758 |
| H-index | 15 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 524 | 589 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 567 | 638 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1592 | 1643 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.07 |
| Self-Citation Percentage |
5.97%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.